Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-02

Clinical Trial Update: Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users [Phase 2]

View source ↗

Summary

Phase 2 pilot study of ibudilast to reduce neuroinflammation in methamphetamine users has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ibudilast (ibudilast)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Methamphetamine-dependence | Phase 2 | Status: COMPLETED